Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Cancer Immunol Res. 2014 Dec 19;3(4):326–332. doi: 10.1158/2326-6066.CIR-14-0133

Table 3.

Univariate analysis of likelihood of pCR on Yale Neoadjuvant Cohort

Univariate
Variable Odds
Ratio*
95% CI P-value
Age (y)
 <50 1
 ≥50 0.923 0.377-2.259 0.8609
Nodal Status
 Positive 0.126 0.042-0.379 0.0002
 Negative 1
Tumor Size (cm)
 <2 1
 >2 0.383 0.101-1.449 0.1575
Nuclear Grade
 1-2 1
 3 2.485 0.983-6.278 0.0543
ER
 Negative 1
 Positive 0.488 0.197-1.209 0.1211
PR
 Negative 1
 Positive 0.415 0.167-1.030 0.0579
HER2
 Negative 1
 Positive 2.357 0.901-6.167 0.0806
Triple Negative
 No 1
 Yes 2.222 0.831-5.941 0.1115
LPBC
 No 1
 Yes 4.697 1.036-21.302 0.0449
Epithelial PD-L1
 Low 1
 High 2.667 0.945-7.528 0.0639
Stromal PD-L1
 Low 1
 High 2.804 0.982-8.006 0.0541
*

Odds Ratio indicates likelihood of pCR